Pasireotide ≥98% - Peptide Manufacturer

Interested? Contact us ↓↓

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on skype
Share on email
Remetide News Express

Introduction from Drug peptide supply about PASIREOTIDE/396091-73-9

chemical formula of Pasireotide


English name PASIREOTIDE
Chinese name 帕瑞肽
CAS NO 396091-73-9
Peptide sequence Cyclo[Hyp(2-aminoethylcarboxyl)-Phg-DTrp-Lys-Tyr(Bzl)-Phe]
Molecular formula C58H66N10O9
Molecular weight 1047.23
storage temperature 2-8℃
purity ≥98%
Package 1mg;5mg;10mg;50mg;100mg,1g or according to customer’s detail requirement.
Product English synonyms Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl];SOM320;[(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl]N-(2-aminoethyl)carbamate

Pasireotide overview

Pasireotide bis-aspartate, is a growth hormone inhibitor analog, in the study of growth hormone (GH) releasing factor, in the experiment of distribution in the hypothalamus of mice, a peptide that can inhibit the release of GH was accidentally discovered , this peptide is named somatostatin (SS), which is a 14-amino acid cyclic peptide that acts through the somatostatin receptor on the cell membrane.

Pharmacological effects of pasireotide

There are currently five known somatostatin receptor subtypes in humans: SST1, SST2, SST3, SST4, and SST5. The SST5 subtype is frequently overexpressed in adrenocorticotropic tumor cells from patients with Cushing’s disease, whereas other receptor subtypes are often absent or expressed at low levels. Pasireotide bis-aspartate is a somatostatin analog with a high affinity for SST5, which binds and activates somatostatin receptors to inhibit the secretion of adrenocorticotropic hormone, resulting in decreased secretion of cortisol, thereby relieving illness.

Market prospect of pasireotide

As a somatostatin analog that can bind to multiple receptors, pasireotide is used in the treatment of acromegaly, carcinoid and Cushing’s disease, whether in preclinical tests such as cell experiments, animal experiments, or in clinical In the test, compared with somatostatin analogs such as octreotide and lanreotide, more significant effects were obtained. The results of the phase II trial of pasireotide and the results of one phase III trial have confirmed that pasireotide is a new treatment for new or persistent acromegaly and metastatic carcinoid tumors. may become the first choice for drug treatment.

How to buy pasireotide in the U. S.

Remetide Peptide Supplier specializes in the production and sales of peptides in the USA, as well as professional peptide R&D. Feel free to contact us if you have any questions or inquiries about Peptides.


Hot line:+19498788363